Skip to main content

Animations

MJFF Publications

4981 - 4990 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2024
  • 2023
  • 2023
  • 2024
  • 2025
  • 2024
  • 2024
  • 2022
  • 2024
  • Summary Details
    OPEN
    Title: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adt2050
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adn6016
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.ade1282
    Citation Count: 32
  • Summary Details
    OPEN
    Title: From policy to practice: Lessons learned from an open science funding initiative
    Journal Name: PLOS Computational Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pcbi.1011626
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Accurate single-molecule spot detection for image-based spatial transcriptomics with weakly supervised deep learning
    Journal Name: Cell Systems
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.cels.2024.04.006
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.115355
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuron.2024.06.002
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Targeted micro-fiber arrays for measuring and manipulating localized multi-scale neural dynamics over large, deep brain volumes during behavior
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuron.2023.12.011
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Presynaptic autophagy is coupled to the synaptic vesicle cycle via ATG-9
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuron.2021.12.031
    Citation Count: 81
  • Summary Details
    OPEN
    Title: Dopamine neuron activity encodes the length of upcoming contralateral movement sequences
    Journal Name: Current Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.cub.2024.01.067
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.